Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MedX Health ( (TSE:MDX) ) just unveiled an announcement.
MedX Health Corp. has announced a proposed non-brokered private placement to raise up to $2.5 million, which will be used to further develop its SIAscopy® on DermSecure® telemedicine platform and expand into the occupational health market. Additionally, the company has granted 500,000 stock options to a consultant, with a total of 6,950,000 options still available under its Incentive Stock Option Plan.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. The company offers the SIAscopy® technology integrated into the DermSecure® platform, which provides accurate imaging of skin lesions for rapid dermatologist review. MedX’s products are approved for use in several countries, including Canada, the U.S., Australia, and the European Union.
Average Trading Volume: 138,305
Technical Sentiment Signal: Buy
Current Market Cap: C$25.65M
For an in-depth examination of MDX stock, go to TipRanks’ Overview page.

